HomeGLSI • NASDAQ
add
Greenwich Lifesciences Inc
Previous close
$14.57
Day range
$14.08 - $17.99
Year range
$7.78 - $17.99
Market cap
238.44M USD
Avg Volume
260.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.17M | 52.97% |
Net income | -4.15M | -55.57% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.17M | -53.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.81M | -34.61% |
Total assets | 3.81M | -34.64% |
Total liabilities | 1.62M | 92.55% |
Total equity | 2.18M | — |
Shares outstanding | 13.85M | — |
Price to book | 91.06 | — |
Return on assets | -301.11% | — |
Return on capital | -575.90% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -4.15M | -55.57% |
Cash from operations | -2.67M | -3.38% |
Cash from investing | — | — |
Cash from financing | 3.35M | 183.82% |
Net change in cash | 681.88K | 148.62% |
Free cash flow | -2.67M | -20.64% |
About
Founded
2006
Headquarters
Website
Employees
4
